Loading BSD 13F portfolios...
Elite Manager Tracking
The Top 150 BSDs
Real-time 13F holding analysis for the industry's most influential institutional investors. Track conviction shifts, new entries, and structural exits.
Real-time 13F holding analysis for the industry's most influential institutional investors. Track conviction shifts, new entries, and structural exits.

Institutional Investor • TCG Crossover
Value
$3.0B
Stocks
48 Stocks
Turnover
0.0%
Top Holdings
ABVX(19.43%) TNGX(6.89%) CGON(6.33%) COGT(4.56%) IMVT(4.17%)
Investment philosophy details pending verification.
| Ticker | P/C | Company Name | Sector | Market Value | Shares | Weight | Chg Shares | % Chg |
|---|---|---|---|---|---|---|---|---|
| ABVX | None | Abivax SA | Healthcare | $800.6M | 0 | 19.4% | 0 | No Change |
| TNGX | None | Tango Therapeutics | General | $283.9M | 0 | 6.9% | 0 | No Change |
| CGON | None | CG Oncology, Inc. | Healthcare | $260.8M | 0 | 6.3% | 0 | No Change |
| COGT | None | COGENT BIOSCIENCES INC | General | $187.9M | 0 | 4.6% | 0 | No Change |
| IMVT | None | Immunovant Inc. | General | $171.8M | 0 | 4.2% | 0 | No Change |
| SYRE | None | Spyre Therapeutics, Inc. | General | $168.7M | 0 | 4.1% | 0 | No Change |
| DNTH | None | Dianthus Therapeutics | General | $163.4M | 0 | 4.0% | 0 | No Change |
| MIRM | None | Mirum Pharmaceuticals, Inc. | Health Care | $124.3M | 0 | 3.0% | 0 | No Change |
| ZLAB | None | Zai Lab Limited | General | $116.6M | 0 | 2.8% | 0 | No Change |
| AMLX | None | AMYLYX PHARMACEUTICALS INC | General | $112.1M | 0 | 2.7% | 0 | No Change |
| Ticker | Amount | % Chg | Weight | Status |
|---|---|---|---|---|
| No recent buys. | ||||
| Ticker | Amount | % Chg | Weight | Status |
|---|---|---|---|---|
| No recent sells. | ||||
| Sector | Stocks | Value | Exposure |
|---|---|---|---|
| General | 44 | $2870.5M | 69.7% |
| Healthcare | 3 | $1125.2M | 27.3% |
| Health Care | 1 | $124.3M | 3.0% |